iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBrookstone Capital Management
Latest Disclosed Ownership6,449 shares
Latest Disclosed Value $ 1,088,995
Brookstone Capital Management reports 46.41% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 16, 2026 - Brookstone Capital Management filed a 13F-HR form disclosing ownership of 6,449 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,088,995 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 12,035 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -46.41% during the quarter. The current value of the position is $845,141 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,449 -5,586 -46.41 1,089 -46.43 0.0124
2026-01-15 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,035 5,735 91.03 2,031 123.43 0.0232
2025-10-15 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,300 -8,520 -57.49 910 -51.49 0.0109
2025-07-30 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,820 6,774 84.19 1,875 82.12 0.0246
2025-04-29 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,046 12 0.15 1,029 -3.11 0.0147
2025-01-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,034 -973 -10.80 1,062 -18.99 0.0155
2024-10-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,007 -11,110 -55.23 1,311 -55.47 0.0193
2024-07-18 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,117 13,488 203.47 2,944 223.87 0.0488
2024-04-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,629 -124 -1.84 910 -0.87 0.0163
2024-01-11 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,753 269 4.15 917 20.34 0.0178
2023-10-20 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,484 3,925 153.38 763 139.62 0.0167
2023-07-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,559 576 29.05 318 20.45 0.0064
2023-04-19 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,983 -6,382 -76.29 265 -76.28 0.0052
2023-01-09 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,365 -600 -6.69 1,114 4.31 0.0225
2022-10-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,965 6,982 352.09 1,067 325.10 0.0247
2022-07-11 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,983 -1,268 -39.00 251 -40.66 0.0056
2022-04-12 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,251 751 30.04 423 20.51 0.0083
2022-01-11 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,500 -1,893 -43.09 351 -48.68 0.0060
2021-11-03 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,393 -1,088 -19.85 684 -22.45 0.0123
2021-07-14 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,481 1,696 44.81 882 54.74 0.0158
2021-04-16 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,785 1,217 47.39 570 46.53 0.0218
2021-01-13 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,568 488 23.46 389 37.94 0.0155
2020-10-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,080 -2,012 -49.17 282 -49.55 0.0130
2020-07-21 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 4,092 4,092 559 0.0348
2019-07-24 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -1,984 -100.00 0 -100.00
2019-04-18 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,984 1,984 222 0.0144
2017-01-12 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -1,969 -100.00 0 -100.00
2016-10-28 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,969 1,969 0.00 570 0.0628
2016-04-14 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDAQ BIOTECHNOLOGY ETF 464287556 0 0 0 0.0000
2016-01-14 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDAQ BIOTECHNOLOGY ETF 464287556 0 -8,133 -100.00 0 -100.00
2015-10-28 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDAQ BIOTECHNOLOGY ETF 464287556 8,133 1,893 30.34 2,467 7.17 0.4474
2015-08-11 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF NASDAQ BIOTECHNOLOGY ETF 464287556 6,240 6,240 2,302 0.2896
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.